Searchable abstracts of presentations at key conferences in endocrinology

ea0013p113 | Clinical practice/governance and case reports | SFEBES2007

Adrenal emergencies in treated addison’s disease

White Katherine , Wass John , Elliott Alyson

Adrenal crisis is a life-threatening emergency requiring immediate treatment with high glucocorticoid doses. In diagnosed Addison’s disease between 3.8% and 29% of patients are estimated to need emergency hospital treatment per annum (Arlt & Allolio, 2003; Fleming & Ostergaard Kristensen, 1999).In 2003 we conducted the largest international survey of diagnosed Addison’s patients to date (N=868), enquiring about the causes and fre...

ea0013p114 | Clinical practice/governance and case reports | SFEBES2007

Inheritance in autoimmune addison’s: the extended family profile

White Katherine , Wass John , Elliott Alyson

Autoimmune hypoadrenalism (Addison’s disease) is a rare condition with a European prevalence of up to 140 per million1. It frequently occurs in association with other organ-specific autoimmune diseases, both endocrine and non-endocrine. These conditions are recognised to occur in the extended family, but their prevalence has been hard to determine, because of the rarity of the disease.In 2003 we conducted the largest international survey ...

ea0015p308 | Steroids | SFEBES2008

Adrenal emergency is a regular event for treated Addison’s patients

White Katherine , Wass John , Elliott Alyson , Arlt Wiebke

Acute adrenal insufficiency requires immediate treatment with high-dose glucocorticoid and represents a life-threatening emergency. Previous research suggests that primary hypoadrenalism patients (Addison’s disease) are more vulnerable to adrenal emergency than steroid-dependent pituitary patients (Arlt & Allolio 2003).In 2006, we surveyed the membership of the UK Addison’s disease Self-Help Group, comprising 982 hypoadrenalism patients, an...

ea0015p329 | Steroids | SFEBES2008

Use of placebo for withdrawal of steroid therapy is contraindicated in adrenal insufficiency

White Katherine , Elliott Alyson , Hawks Noel , McEntegart Mary

Adrenal insufficiency (AI) patients who are deprived of regular steroid replacement therapy rapidly become unwell. However, the interval for which AI patients might safely be withdrawn from steroid medication for clinical purposes, such as re-assessment of adrenal reserve, is largely a matter of speculation, since it would be difficult to construct an ethical trial on this matter. Valuable insights into this dilemma can be gained from the case studies of an early clinical rese...